https://stock.noler.com/us/stock/cornerstone-therapeutics-inc https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accounts-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accounts-receivable-net-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accrual-product-liability-net https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/acquired-contingent-liability https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/acquisition-integration-related-costs https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/acquisitions https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/advertising-expense https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/allowance-for-doubtful-other-receivables-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/amortization https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-contingent-consideration-at-fair-value https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-contingent-consideration-at-fair-value-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-contingent-consideration-at-fair-value-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-cost-of-acquired-entity-purchase-price https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-pro-forma-earnings-per-share-diluted https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-assets-acquired-liabilities-assumed-net https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-current-assets-cash-and-cash-equivalents https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-current-assets-inventory https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-current-assets-receivables https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-current-liabilities-accounts-payable https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-current-liabilities-accrued-liabilities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-goodwill-amount https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-goodwill-expected-tax-deductible-amount https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisition-purchase-price-allocation-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/clinical-trials https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/cost-of-goods-sold https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/current-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/debt-issuance-costs https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/debt-issued https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-assets-valuation-allowance-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/due-from-related-parties-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/eps https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-amortization-expense https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/goodwill https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/goodwill-acquired https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/goodwill-purchase-accounting-adjustments https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/income-tax https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/income-taxes-receivable https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/insider-transactions-other/purchases https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/interest-expense-related-party https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/interest-income-expense-net https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/inventory https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/inventory-finished-goods https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/inventory-gross https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/inventory-raw-materials https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/iran-activity-notices-irannotice https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/licenses-revenue https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/net-income https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/noncash-or-part-noncash-acquisition-other-liabilities-assumed https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/number-of-defendants https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/operating-income https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-cost-and-expense-operating https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-income https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-nonoperating-expense https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-receivables https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-sales-revenue-net https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/other-significant-noncash-transaction-value-of-consideration-given https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/payments-for-proceeds-from-productive-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/payments-to-acquire-other-productive-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/proceeds-from-divestiture-of-businesses https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/provision-for-other-losses https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/public-float https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/related-party-transaction-purchases-from-related-party https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/repayments-of-other-debt https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/revenue https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/royalty-expense https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sales-allowances-goods https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sales-discounts-goods https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sales-revenue-goods-gross https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-15-12g https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-425 https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-ars https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-defm14a https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-dfan14a https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-prem14a https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-prer14a https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-regdex https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-s-4 https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sec-filings-sc-13e3 https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/significant-supply-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/taxes-payable-current-and-noncurrent https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/total-assets https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/utb-change https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/utb-income-tax-penalties-accrued https://stock.noler.com/us/stock/cornerstone-therapeutics-inc/utb-interest-on-income-taxes-accrued